Bing Z Carter

12PUBLICATIONS
74CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 13, 2026
The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and TP53-Mutant AML.

|Aug 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community.

Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz

|Dec 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.

Hiroki Akiyama, Ran Zhao, Lauren B Ostermann

|Nov 29, 2023
Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias.

Yuki Nishida, Jo Ishizawa, Edward Ayoub

|Jun 20, 2023
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.

Bing Z Carter, Po Yee Mak, Muharrem Muftuoglu

|Apr 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia.

Christina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis

Pageof 2

Frequent Collaborators

12 joint publications

Michael Andreeff

8 joint publications

Lauren B Ostermann

5 joint publications

Steffen Boettcher

4 joint publications

Edward Ayoub